J&J’s Surgical Robot Wins US FDA Marketing Authorisation, Is It Affordable?
Johnson & Johnson is holding out its full commercial rollout until it obtains approvals for urological procedures.

Johnson & Johnson said that the US Food and Drug Administration (US FDA) had granted marketing authorisation for its robotic surgery device. This marks the healthcare conglomerate’s entry into the soft-tissue robotic surgery market.
Johnson & Johnson’s Ottava robotic surgical platform received regulatory clearance for use across a variety of general abdominal surgical procedures. This includes procedures like gastric bypass, gastrectomy, gallbladder removal, gastric sleeve surgery, appendectomy, and hiatal hernia repair.
The company stated the robotic arms of the Ottava are built directly into the operating table. This makes them effectively use 30% to 50% less physical space than the standalone cart-and-boom setups utilised by most other surgical robots.
Johnson & Johnson is holding out its full commercial rollout until it obtains approvals for urological procedures.
Recent studies show that robot-assisted surgeries are generally more expensive. J&J, however, said it would begin a US commercial launch with select customers. It also revealed that expanding the system into additional regulatory markets is in the works.
While the timing has not been revealed yet, the CEO told Reuters, “Our intention is to lead in surgical robotics… we’re also planning fast launches in key markets globally, like Japan and Western Europe.”
Robot24.com Business News TAKE:
Studies consistently show the success rates, reduced operative times, and improved patient functional outcomes of AI robotic surgery. The company has yet to disclose pricing, and the initial robots are limited to a few select US customers. The pricing will tell if Johnson & Johnson can compete with established robotic surgery systems
More articles on this topic
278 articles
ReportChina Is Sending Humanoid Robots To School
ReportWhat it Really Costs to Own a Personal Assistant Robot at Home
ReportHumyn Labs Raises $47 Million to Build Real-World Training Data for Robotics
ReportBoston Dynamics Selects GlobalFoundries as First Semiconductor Customer for Atlas Humanoid Trials
ReportGenesis AI Raises $500 Million at a $3.5 Billion Valuation to Scale General-Purpose Robots
ReportMultiway Robotics Showcases Intralogistics Solutions and Wheeled Humanoid at CeMAT ASIA
ReportFORT Robotics Files Registration Statement for Public Listing Partnership
ReportRobot Baristas are Learning to Reproduce the Art of Professional Coffee Making
ReportTARSBOT and Aptiv Plan to Deploy 100 Industrial Robots Across 33 Factory Applications
ReportSouth Korea Proposes $39 Million for Robot Actuators, Humanoid Batteries and AI Sensors
ReportLoongson Completes ROS 2 Integration on Its Domestic Computing-Powered Intelligent Robot Vehicle
ReportBoston Dynamics Puts Wheels on Atlas Humanoid to Test Reinforcement Learning and Motor LimitsBUSINESS NEWS WEEKLY LETTER
The Weekly Letter for Robotics Professionals, Summarizing the Most Important Industry Moves, Launches, Deals and Signals.